The Other Side of the Lens
Practitioners should keep tabs on new contact lens innovation such as drug delivery.
Translating Clinical Trial Results to Practice
The clinical research process that takes a promising new treatment from initial investigation through US Food and Drug Administration (FDA) approval
Spring Into Action this Allergy Season
With seasonal allergies expected to start earlier this year, it’s never too soon to make
sure you’re up to date with the latest treatment options.
Unmet need spurs research
Therapy for chronic ocular allergy a major focus for drug development
VKC and the Allergy Rogues Gallery
What sets vernal keratoconjunctivitis apart from other allergic conditions, and how to create targeted treatments for it.
Therapies offer relief to many patients
Treatments for ocular allergy have come a long way, but still have miles to go
Treating the Problem: Fungal Keratitis
Stay up-to-date on the current treatment regimens and future therapies for fungal keratitis infection.
Anti-VEGF State of the Union
Business of Retina Clinical Trials for the Retina Specialist
Acanthamoeba Creeps into the Light
Clearing up misconceptions about the Acanthamoeba infection in light of recent outbreaks.
RegeneRx Reports Positive Data with RGN-259 in Phase 2 Dry Eye Trial
A sterile, preservative-free eye drop, to evaluate its safety and efficacy for the treatment of signs and symptoms of dry eye